H2020Индивидуална стипендия2015–2017

STEMCELLTRACK · Assessment of Global and Regional Cardiac Functional Improvements in a Murine Model of Myocardial Infarction following Stem Cell Treatments

„Хоризонт 2020“ — Действия „Мария Склодовска-Кюри“

Период
2015-07-01 → 2017-06-30
Финансиране от ЕС
183 455 €
Участници
1
Схема
MSCA-IF-EF-ST

Линиите свързват координатора с партньорите.

Накратко на български

Стволовите клетки при миокарден инфаркт се проследяват чрез специализиран магнитен резонанс и полимерни структури при мишки. Това помага да се разбере как клетките се разпространяват и оцеляват, за да се подобри ефективността на бъдещи терапии при сърдечни заболявания.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Резултати накратко

Assessment of Global and Regional Cardiac Functional Improvements in a Murine Model of Myocardial Infarction following Stem Cell Treatments

Cardiac progenitor stem cell (CPC) therapy for myocardial infarction (MI) has been shown to elicit moderate beneficial effects. Research currently focuses on improving CPC administration, retention, and efficacy. The conducted project work achieved the development of Magnetic Resonance Imaging (MRI) and engineering tools to facilitate this research in normal mice. Intra-cardiac injections of CPCs labeled with perflurocrown-ether (PFCE) nanoparticles (NPs) and with the highly efficient transfection agent FuGENE can be visualized and tracked for the first time with 19F MRI in mice for approximately 8 days. The primary mechanisms attributing cellular status and temporal signal changes have been investigated, and have been shown to include (among others) possible: a) CPC migration/dispersion, b) cell death, and c) macrophage infiltration and scavenging. Furthermore, the developed methodologies achieved in vivo cardiac 19F MRI of injected labeled CPCs by reducing imaging acquisition to a few minutes, providing evidence for their potential for possible translational work. Parallel to these studies there was an independent design, synthesis, use, and evaluation of a polymeric scaffolds. Overall, we have shown that porous, medium-chain length poly-caprolactone/poly(3-hydroxyoctanoate) polymer blends have superior performance in terms of the seeding density, adhesion, and CPC viability/proliferation. The choice of this material underlines one of the important novelties of pursued work, given its elastomeric nature, mechanical properties, and its potential to be conjugated with vascular growth factors and peptides to further prolong cellular attachment, viability, and proliferation. Its structural advantages/morphological characteristics are tunable and allow maximization of the seeding density for faster detection and temporal follow-up using direct, 19F MRI/MRS in vivo for at least 9 days post-implantation, as documented in mice. Through a personalized career development plan, the fellowship allowed training of the researcher in advanced cellular characterization, synthesis, labeling, and bio-imaging techniques, synergistically with trans-European mobility through two secondments, reinforcing his scientific and managerial qualities.

Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз

Цел на проекта

Cardiosphere-derived stem cell (CDC) therapy for myocardial infarction (MI) has been shown to elicit moderate beneficial effects. Research currently focuses on improving CDC administration, retention and efficacy. This proposal aims to develop Magnetic Resonance Imaging (MRI) and engineering tools to facilitate this research. Specifically, microinjection of fluorine-19 labeled CDCs will allow for MRI tracking and quantification in vivo. Non-invasive global and regional cardiac function measurements will assess efficacy of stem cell (SC) therapy. Parallel to these studies will be an independent design, synthesis, use and evaluation of fiber-enriched scaffold. The anticipated impact will be multifaceted, including the study of cardiac function in disease, and the potential applicability of generated results with cutting edge SC regenerative technologies in heart failure and prominent cardiomyopathies. Research efforts will be stimulated in manufacturing processes for scaffolds, cardiac functional assessment post-injection of SCs, and validation of their homing, engraftment and viability using cellular tracking methods.Through a personalized career developments plan, the fellowship will allow training of the researcher in advanced cellular characterization, labeling, and bio-imaging techniques, synergistically with trans-European mobility, reinforcing his scientific, managerial and leadership qualities. Overall, the short-term objective is the advancement of the researcher’s career in science and the broadening of his scientific horizons. The long-term objective is to establish the researcher as an independent investigator, advancing the field as a chair of a Biomedical Engineering Department.

Оригинален текст от CORDIS (на английски).

Участници

Връзки

Данни: CORDIS, © Европейски съюз